Authors:
Milenic, DE
Roselli, M
Mirzadeh, S
Pippin, CG
Gansow, OA
Colcher, D
Brechbiel, MW
Schlom, J
Citation: De. Milenic et al., In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates, CANC BIO R, 16(2), 2001, pp. 133-146
Authors:
Kashmiri, SVS
Iwahashi, M
Tamura, M
Padlan, EA
Milenic, DE
Schlom, J
Citation: Svs. Kashmiri et al., Development of a minimally immunogenic variant of humanized anti-carcinomamonoclonal antibody CC49, CR R ONC H, 38(1), 2001, pp. 3-16
Authors:
Chappell, LL
Dadachova, E
Milenic, DE
Garmestani, K
Wu, CC
Brechbiel, MW
Citation: Ll. Chappell et al., Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes Pb-203 and Pb-212, NUCL MED BI, 27(1), 2000, pp. 93-100
Authors:
Tamura, M
Milenic, DE
Iwahashi, M
Padlan, E
Schlom, J
Kashmiri, SVS
Citation: M. Tamura et al., Structural correlates of an anticarcinoma antibody: Identification of specificity-determining residues (SDRs) and development of a minimally immunogenic antibody variant by retention of SDRs only, J IMMUNOL, 164(3), 2000, pp. 1432-1441
Authors:
Roselli, M
Milenic, DE
Brechbiel, MW
Mirzadeh, S
Pippin, CG
Gansow, OA
Colcher, D
Schlom, J
Citation: M. Roselli et al., In vivo comparison of CHX-DTPA ligand isomers in athymic mice bearing carcinoma xenografts, CANC BIO R, 14(3), 1999, pp. 209-220
Authors:
Iwahashi, M
Milenic, DE
Padlan, EA
Bei, R
Schlom, J
Kashmiri, SVS
Citation: M. Iwahashi et al., CDR substitutions of a humanized monoclonal antibody (CC49): contributionsof individual CDRs to antigen binding and immunogenicity, MOL IMMUNOL, 36(15-16), 1999, pp. 1079-1091